Page 12 - MedTech 2021
P. 12

                  SINGAPORE MEDTECH DIRECTORY 2020/2021
 schedules and uses customised reminders through SMS to help users stay on track. It also displays a Personal Adherence Score. Designed with patient-empowerment as top priority, smart connected devices such as this have demonstrated ability to improve medication adherence by as much as 27 per cent. HealthBeacon is based in Ireland but is expanding to Asia following an investment by SGInnovate in 2019.
There has been an increase in the development and adoption of home- monitoring solutions, where patients can track factors like blood sugar, weight, and blood pressure without having to visit a clinic or take a lab test.
WEB Biotechnology, a digital heart health company headquartered in Singapore, developed Spyder ECG, a wearable device that continuously monitors the heart’s electrical activity through a smartphone and transmits this data to a cloud database. Artificial Intelligence (AI) is applied to the data to analyse electrocardiography (ECG) rhythm abnormalities in real-time. Physicians can remotely log into the database and report findings to patients from another connected device. The Spyder system is a ‘world’s first’, using digital and cloud- based technologies to simplify collection of continuous ‘live-streamed’ ECG from any connected location world-wide.
AI-driven Technology
As MedTech becomes increasingly reliant on data, AI has become indispensable to the industry, according to Deloitte. This is reflected in global investment in healthcare AI companies, which amounted to almost US$1.6 billion in Q3 2019.
The use of AI in MedTech can be seen in descriptive and predictive analytics, chatbots for wellness coaching, and imaging analysis.
Singapore-based KroniKare enables almost-instant, non-invasive assessment of chronic wounds with the use of an AI- enabled scanning device. Using cutting- edge Machine Learning, Image Processing, and multi-modal Data Analysis, the device measures the wound and evaluates it
against 15 years of chronic wound data. A report is generated, which healthcare practitioners can use to determine suitable treatments.
Singapore’s existing AI expertise and infrastructure is advantageous for MedTech companies.
“AI in health is typically predicted to be felt first in imaging, and Singapore is ahead of the curve in retinal imaging through the Singapore National Eye Centre,” says Prof Robert Morris, Chief Technology Strategist of Ministry of Health Office for Healthcare Transformation (MOHT). However, with limited approval of AI-based medical devices, MedTech startups now have a better appreciation of regulatory barriers, which can affect product development.

   10   11   12   13   14